Beitrage zur Infusionstherapie = Contributions to infusion therapy最新文献_第3页

[Partially automated antigen determination and antibody detection with microtiter plates]. [微滴板部分自动化抗原测定和抗体检测]。

Beitrage zur Infusionstherapie = Contributions to infusion therapy Pub Date : 1993-01-01

C Rapp, C Weisshaar

{"title":"[Partially automated antigen determination and antibody detection with microtiter plates].","authors":"C Rapp, C Weisshaar","doi":"","DOIUrl":"","url":null,"abstract":"In addition to several conventional methods for the detection of red cell antigens, the use of microplates has various advantages either as a solid-phase assay (enzyme immunoassay) or as native microplate. Microplates may also be used for the detection of red cell antibodies in 'pooled-cell solid-phase assays' of the second generation and for antibody screening. Blood donors and patients are the two main fields which are to be examined in immunohematology. There are various advantages in using the microplate in blood group serology: (i) if there is hardware already available, like sample processors and microplate readers, the use of microplates in blood group serology reduces the costs even if the equipment has to be purchased for this purpose only; (ii) low quantities of reagents are used in microplate assays; (iii) the application of bar codes on tubes and microplates guarantees the most security in sample identification; (iv) it is possible to investigate blood samples selectively depending on the available software if antibody detection is done as the sixth test beside anti-HIV, anti-HCV, HBsAG, lues antibodies and ALT, and (v) recording of data will be easy if electronic data processing is used.","PeriodicalId":77034,"journal":{"name":"Beitrage zur Infusionstherapie = Contributions to infusion therapy","volume":"31 ","pages":"157-61"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18696026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Indications for irradiated blood components: dose and side effects]. 【辐照血液成分的适应症:剂量和副作用】。

Beitrage zur Infusionstherapie = Contributions to infusion therapy Pub Date : 1993-01-01

T H Eiermann

引用次数: 0

[(Partially) automated gel techniques for determining erythrocyte antigens and antibodies]. 测定红细胞抗原和抗体的(部分)自动凝胶技术。

Beitrage zur Infusionstherapie = Contributions to infusion therapy Pub Date : 1993-01-01

B Kreutzig, D Weisshaar

{"title":"[(Partially) automated gel techniques for determining erythrocyte antigens and antibodies].","authors":"B Kreutzig, D Weisshaar","doi":"","DOIUrl":"","url":null,"abstract":"Today, in addition to the classical test tube technology to determine red blood cell antigens and antibodies, not only the microtitration plate is increasingly used, but also the gel card. Since this new technology is easy to practice and since it further provides a higher specificity and sensitivity, we investigated whether, and if so to what extent, the gel card can be automated. On the basis of our own experience spanning many years, we were able to show that antigen determinations and antibody screening can be automated. Once the samples to be tested and the tests to be performed have been recorded by electronic data processing and combined in a job list, any sampler can distribute liquids, such as reagents and serum and/or plasma as well as red blood cell suspensions, on the basis of these data. A positive sample identification is made feasible by bar coding sample tubes and gel cards; the pipetting action is organized via the bar codes. Incubation and centrifugation are of secondary importance for automation. At this time, an automatic evaluation of gel cards is not yet possible so that result interpretation must be visual and the input of results must be manual. For documentation, however, laboratory books and result interpretation reports can be printed out automatically.","PeriodicalId":77034,"journal":{"name":"Beitrage zur Infusionstherapie = Contributions to infusion therapy","volume":"31 ","pages":"152-6"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18696025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Thrombocyte substitution in hematologic patients]. 血液病患者的血小板替代。

Beitrage zur Infusionstherapie = Contributions to infusion therapy Pub Date : 1993-01-01

M Wiesneth

引用次数: 0

[Preliminary results of the 2nd multicenter study. Thrombocytapheresis with the Fresenius AS-104 blood cell separator and ring study of cell counting. Section of Therapeutic and Preparative Hemapheresis of the DGTI]. [第二次多中心研究的初步结果]使用费森尤斯AS-104血细胞分离器进行血小板穿刺和细胞计数环研究。DGTI的治疗性和制备性采血部分]。

Beitrage zur Infusionstherapie = Contributions to infusion therapy Pub Date : 1993-01-01

N Müller, V Kretschmer, H J Neumann, T Weisswange

引用次数: 0

[Detection of drug-induced antibodies to erythrocytes in the gel test]. 【凝胶试验中药物诱导红细胞抗体的检测】。

Beitrage zur Infusionstherapie = Contributions to infusion therapy Pub Date : 1993-01-01

H Kroll, A Salama, H Berghöfer, M Ernst-Schlegel, C Mueller-Eckhardt

引用次数: 0

[Quality assurance in preoperative autologous blood collection from the viewpoint of the anesthetist]. 从麻醉师的角度看术前自体采血的质量保证。

Beitrage zur Infusionstherapie = Contributions to infusion therapy Pub Date : 1993-01-01

G Singbartl, W Schleinzer

{"title":"[Quality assurance in preoperative autologous blood collection from the viewpoint of the anesthetist].","authors":"G Singbartl, W Schleinzer","doi":"","DOIUrl":"","url":null,"abstract":"From the anesthetist's point of view the following safety measures regarding autologous blood donation have to be considered: [1] inclusion/exclusion criteria for the patient's selection; [2] quality control of the autologous product itself and [3] adequate technical standards of the equipment applied. There is no doubt, the criteria used for the patient's selection of an autologous predeposit program have a great impact both on the number and the severity of complications that might occur. Anesthetists consider a patient eligible for an autologous predeposit program if he/she is considered eligible for an elective operative procedure, too; since this means that this patient demonstrates compensated organ functions (e.g. of the cardiovascular system, of the pulmonary function as well as of the metabolic and hematopoietic system). As shown by data in the literature, these criteria even hold true in patients with serious (but compensated) concomitant diseases. In contrast to the routine procedure of homologous donation, monitoring of a patient during the autologous predeposit procedure as well as an adequate replacement of the volume of the autologous predeposit donated appear to be reasonable, especially in patients with serious risk factors. Following this concept, the number of undesired side effects during the autologous donation is in the same order as it is known from healthy volunteers for homologous donation. It appears wise to apply the same safety and quality standards for an autologous predeposit as for the comparable homologous products. Most important and without any restriction, the autologous product has to be safe for the patient: there should be no bacterial contamination of the autologous product, and the corpuscular content of the autologous plasma should not exceed a definite limit.(ABSTRACT TRUNCATED AT 250 WORDS)","PeriodicalId":77034,"journal":{"name":"Beitrage zur Infusionstherapie = Contributions to infusion therapy","volume":"31 ","pages":"193-201"},"PeriodicalIF":0.0,"publicationDate":"1993-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18697724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Historical development of blood transfusion]. [输血的历史发展]。

Beitrage zur Infusionstherapie = Contributions to infusion therapy Pub Date : 1993-01-01

J Benedum

引用次数: 0

[Changes in blood coagulation physiology of wound blood]. [伤口血液凝血生理变化]。

Beitrage zur Infusionstherapie = Contributions to infusion therapy Pub Date : 1993-01-01

H Trobisch

引用次数: 0

Erythropoietin--does it increase the efficiency of autologous blood donation? 促红细胞生成素——能提高自体献血的效率吗?

Beitrage zur Infusionstherapie = Contributions to infusion therapy Pub Date : 1993-01-01

L T Goodnough

引用次数: 0